Incresync

alogliptin; pioglitazone · Takeda Pharma A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Incresync, covering 2022-09-09 to 2022-09-09. Get the full timeline:

Most recent: EMA Authorised: Incresync (alogliptin;pioglitazone) — Takeda Pharma A/S